Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to establish a safe and systematic exercise assessment and prescription program for cancer survivors. It can be challenging for cancer patients to start exercising due to various health risks, so this study aims to create a personalized and easily reproducible workflow. The study will include cancer patients who have completed their primary curative treatments at least 2 months ago. Participants will undergo a comprehensive health and fitness evaluation led by a study physician. This evaluation includes: * A review of medical history and cardiovascular risk. * Functional physical fitness tests. * Cardiopulmonary Exercise Testing (CPET) to carefully evaluate heart and lung function during physical exertion. * A musculoskeletal ultrasound, if deemed necessary. Based on these combined results, the medical team will determine each participant's exercise risk level and design a personalized exercise prescription. Participants will then be assigned to an appropriate and safe exercise setting. To ensure safety and maximize health benefits, the study includes a continuous tracking system. Participants will report their exercise progress every 4 weeks and undergo a full reassessment every 3 months. The medical team will use this feedback to safely adjust the participant's risk level and exercise prescription over time.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-80 lat
- •Potwierdzony diagnoza raka w stadium I-III, zakończone pierwsze leczenie (operacja, chemioterapia, radioterapia) co najmniej 2 miesiące temu
- •Dobry stan ogólny (wynik 0-2 w skali wydolności)
- •Możliwość uczestniczenia w 3-4 treningach tygodniowo pod opieką specjalisty
- •Niewystarczająca aktywność fizyczna w ciągu ostatnich 3 miesięcy (mniej niż 150 minut umiarkowanej aktywności lub mniej niż 75 minut intensywnej aktywności tygodniowo)
✗ Disqualifies
- •Problemy z sercem: zawał, niestabilna dusznica bolesna, arytmia, niekontrolowane wysokie ciśnienie (>180/110) w ostatnich 3 miesiącach
- •Zbyt niski poziom tlenu we krwi (<90%)
- •Niestabilny poziom cukru lub cukrzycowa kwasica w ostatnich 3 miesiącach
- •Przerzuty do kości z wysokim ryzykiem złamania, niedawny złamanie lub operacja ortopedyczna
- •Zbyt niska liczba płytek (<50 000), poważna anemia (hemoglobina <8 g/dL) lub zbyt mała liczba białych krwinek
- •Ocena lekarza, że ćwiczenia są zbyt ryzykowne dla pacjenta
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 80 Years
- Last updated (source)
- August 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung, Taiwan
Trial contact
Ko-Long Lin, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.